Genprex Inc (GNPX)
2.48
-0.13
(-5.13%)
USD |
NASDAQ |
May 07, 16:00
2.58
+0.10
(+4.03%)
Pre-Market: 20:00
Genprex Cash from Investing (TTM): -0.0712M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.0712M |
September 30, 2023 | -0.0814M |
June 30, 2023 | -0.0757M |
March 31, 2023 | -0.0775M |
December 31, 2022 | -0.0597M |
September 30, 2022 | -0.2133M |
June 30, 2022 | -0.029M |
March 31, 2022 | 0.0244M |
December 31, 2021 | -0.0838M |
September 30, 2021 | -2.252M |
June 30, 2021 | -2.268M |
March 31, 2021 | -2.310M |
December 31, 2020 | -2.337M |
September 30, 2020 | -0.0874M |
June 30, 2020 | -0.1984M |
Date | Value |
---|---|
March 31, 2020 | -1.071M |
December 31, 2019 | -0.9469M |
September 30, 2019 | -0.919M |
June 30, 2019 | -0.967M |
March 31, 2019 | -0.1062M |
December 31, 2018 | -0.1033M |
September 30, 2018 | -0.0405M |
June 30, 2018 | -0.0543M |
March 31, 2018 | -0.0509M |
December 31, 2017 | -0.0634M |
September 30, 2017 | -0.08M |
June 30, 2017 | -0.127M |
March 31, 2017 | -0.1117M |
December 31, 2016 | -0.0895M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-2.337M
Minimum
Dec 2020
0.0244M
Maximum
Mar 2022
-0.7381M
Average
-0.1984M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
Lifecore Biomedical Inc | -4.153M |
Jaguar Health Inc | 0.00 |
BioXcel Therapeutics Inc | -0.02M |
TFF Pharmaceuticals Inc | -0.0948M |
4D Molecular Therapeutics Inc | 115.72M |